ESR1 and breast carcinoma: Moreover, Bredfeldt et al. [43] showed that the membrane-activated estrogen receptor (ER) signaling pathway by diethylstilbestrol results in PI3K/AKT-mediated pS21-EZH2 increasing and decreasing H3K27me3 level in breast cancer MCF7 cells.